STACEY GERBRANDT: Open Payments
NPI 1083845887 · VALENCIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,106 in 35 payments from 7 companies in 2025. Trend: 2023 $1,370 · 2024 $2,260 · 2025 $1,106
Food & beverage: $1,106
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 26 | $882 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| GENZYME CORPORATION | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $25 |
| Optinose US, Inc. | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
Products named: INSPIRE, DUPIXENT, NUCALA, XHANCE, NEFFY.
Industry payments across CA — which companies pay providers there.
